BiotechTube
Home/OncoBone Therapeutics/Dr. Jussi Halleen, Ph.D.
DJ

Dr. Jussi Halleen, Ph.D.

Chief Executive Officer

OncoBone Therapeutics

Therapeutic Areas

OncologyRare Disease

OncoBone Therapeutics Pipeline

DrugIndicationPhase
OBP-004Bone Metastasis (and other metastases)Preclinical

Leadership Team at OncoBone Therapeutics

DT
Dr. Tiina Kähkönen, Ph.D.
Chief Scientific Officer
View full OncoBone Therapeutics profile